Public Employees Retirement System of Ohio Has $3.37 Million Position in Lineage, Inc. $LINE

Public Employees Retirement System of Ohio boosted its stake in shares of Lineage, Inc. (NASDAQ:LINE) by 119.6% during the first quarter, Holdings Channel.com reports. The fund owned 102,960 shares of the company’s stock after acquiring an additional 56,073 shares during the period. Public Employees Retirement System of Ohio’s holdings in Lineage were worth $3,373,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC lifted its position in shares of Lineage by 172.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 572 shares of the company’s stock valued at $25,000 after acquiring an additional 362 shares during the period. Vanderbilt University increased its position in shares of Lineage by 4.1% in the first quarter. Vanderbilt University now owns 10,925 shares of the company’s stock worth $358,000 after purchasing an additional 431 shares during the period. Allworth Financial LP raised its stake in Lineage by 106.6% in the fourth quarter. Allworth Financial LP now owns 940 shares of the company’s stock valued at $33,000 after purchasing an additional 485 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its stake in Lineage by 33.4% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,005 shares of the company’s stock valued at $70,000 after purchasing an additional 502 shares in the last quarter. Finally, Amundi lifted its position in Lineage by 1.5% during the third quarter. Amundi now owns 35,805 shares of the company’s stock worth $1,481,000 after purchasing an additional 512 shares during the period.

Lineage Stock Performance

Lineage stock opened at $42.85 on Friday. Lineage, Inc. has a 12-month low of $31.33 and a 12-month high of $45.75. The company has a quick ratio of 0.76, a current ratio of 0.85 and a debt-to-equity ratio of 0.82. The business’s 50-day moving average price is $43.04 and its two-hundred day moving average price is $39.12. The stock has a market cap of $9.76 billion, a PE ratio of -69.11 and a beta of 0.85.

Lineage (NASDAQ:LINE) last issued its earnings results on Wednesday, May 6th. The company reported $0.78 EPS for the quarter, topping the consensus estimate of ($0.23) by $1.01. The firm had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.31 billion. Lineage had a negative return on equity of 1.56% and a negative net margin of 2.72%.The business’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.86 earnings per share. As a group, analysts expect that Lineage, Inc. will post 2.46 earnings per share for the current fiscal year.

Lineage Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, July 21st. Investors of record on Tuesday, June 30th were given a dividend of $0.5325 per share. This represents a $2.13 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date was Tuesday, June 30th. Lineage’s dividend payout ratio is currently -343.55%.

Analyst Ratings Changes

A number of brokerages have issued reports on LINE. Evercore set a $44.00 price objective on shares of Lineage in a research note on Monday, June 8th. Scotiabank reaffirmed a “sector perform” rating and set a $45.00 price target on shares of Lineage in a report on Thursday, June 18th. UBS Group increased their price target on shares of Lineage from $35.00 to $45.00 and gave the stock a “neutral” rating in a research report on Friday, July 17th. Wells Fargo & Company reduced their price target on shares of Lineage from $39.00 to $36.00 and set an “equal weight” rating on the stock in a research report on Monday, June 1st. Finally, Morgan Stanley boosted their price objective on shares of Lineage from $39.00 to $47.00 and gave the company an “equal weight” rating in a research report on Tuesday, June 2nd. Five research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $43.38.

Key Headlines Impacting Lineage

Here are the key news stories impacting Lineage this week:

• Positive Sentiment: Lineage’s applications to rebuild the Boyle Heights facility could eventually restore warehouse capacity and revenue-generating operations. However, the reports indicate the company is seeking permits rather than announcing an approved project or construction start. What the Lineage warehouse rebuilding permits actually mean
• Neutral Sentiment: The rebuilding proposal is drawing strong opposition from Boyle Heights residents, parents and local officials, who say the site’s cleanup remains incomplete and that odor concerns could affect nearby schools. The controversy may delay permitting and increase compliance or remediation costs, but no specific financial impact was reported. Boyle Heights parents want answers about schools reopening in the Lineage stench zone
• Negative Sentiment: Los Angeles County health authorities reportedly fined Lineage over rotting food and large numbers of flies at the fire-damaged warehouse and could impose additional daily penalties. Ongoing enforcement raises the risk of higher cleanup expenses, legal exposure and further delays in returning the facility to service. Lineage Fined For Rotting Food, Swarms Of Flies At Burned LA Cold Storage Warehouse
• Negative Sentiment: Local officials, including the mayor, described the rebuilding filing as a “slap in the face,” intensifying political and community scrutiny. That reaction could make approvals more difficult and damage Lineage’s reputation with customers and regulators. Boyle Heights warehouse rebuild prompts outrage
• Neutral Sentiment: One listed article concerns Lineage Cell Therapeutics, a separate company and not Lineage, Inc. (NASDAQ: LINE), so it should not be treated as news affecting LINE. Lineage Cell Therapeutics earnings announcement

About Lineage

Lineage Logistics, Inc (NASDAQ: LINE) is a leading provider of temperature-controlled industrial real estate and supply chain solutions. The company specializes in refrigerated and frozen storage, transportation, and ancillary services designed to support the global perishable goods industry. From food manufacturers and distributors to retailers and foodservice operators, Lineage offers tailored temperature management solutions that help clients optimize inventory turnover, reduce waste, and maintain product quality throughout the cold chain.

Lineage’s core services include ambient, refrigerated and frozen warehousing, cross-docking, transloading, and dedicated transportation.